Pediatric Cancer Clinical Trials in Boston, Massachusetts

6 studies are recruiting for pediatric cancer in Boston, Massachusetts right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Lurbinectedin in FET-Fused Tumors

   The purpose of this study is to find out if a drug called lurbinectedin (the "study drug") is safe and effective at treating people with recurrent or relapsed solid tumors, including Ewing sarcoma.

   Stage

   Phase 1

   Ages

   10 and older

   Site

   Dana-Farber Cancer Institute, Boston, Massachusetts

   Locations

   6 in total

   Run by

   Children's Hospital of Philadelphia

   See if you can join NCT05918640 on ClinicalTrials.gov

2. Multisite Implementation of COMPRENDO

   COMPRENDO (ChildhOod Malignancy Peer Research NavigatiOn) is a multi-site randomized clinical trial (RCT) that uses a Hybrid Type 1 design, to test the effects of a clinical intervention on patient-level outcomes, while exploring multilevel implementation factors that can inform real-world setting …

   Stage

   Not phased

   Ages

   18 and older

   Site

   Dana Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts

   Locations

   4 in total

   Run by

   University of California, San Diego

   See if you can join NCT06055296 on ClinicalTrials.gov

3. Video Inspired Discussions About Ethical Outcomes in Pediatrics

   The goal of this clinical trial is to learn if the VIDEO-PEDS intervention works to improve Goals of Care communication between clinicians and parents of children with cancer. The main questions it aims to answer are: Does the intervention improve Goals of Care documentation? Does it improve patien…

   Stage

   Not phased

   Ages

   Any age

   Site

   Dana Farber Cancer Institute, Boston, Massachusetts

   Locations

   4 in total

   Run by

   Massachusetts General Hospital

   See if you can join NCT06786104 on ClinicalTrials.gov

4. PediRISE Feasibility

   The goal of this research study is to learn whether investigators can successfully give the PediRISE program to families-in other words, whether most families are interested in participating in a study about the PediRISE program, including a 50-50 chance of receiving standard usual care, and a 50-5…

   Stage

   Not phased

   Ages

   Up to 17

   Site

   Boston Children's Hospital, Boston, Massachusetts

   Locations

   4 in total

   Run by

   Dana-Farber Cancer Institute

   See if you can join NCT06283251 on ClinicalTrials.gov

5. Targeted Therapy to Increase RAI Uptake in Metastatic DTC

   Papillary thyroid cancer (PTC) is a common type of differentiated thyroid cancer (DTC) in children and represents the second most common cancer in adolescent females. Recently targeted drugs that block many of the genetic drivers of DTC have become available. While Investigators know that these dru…

   Stage

   Not phased

   Ages

   0 and older

   Site

   Boston Children's Hospital, Boston, Massachusetts

   Locations

   9 in total

   Run by

   Children's Hospital of Philadelphia

   See if you can join NCT05024929 on ClinicalTrials.gov

6. Childhood Cancer Predisposition Study (CCPS)

   The Childhood Cancer Predisposition Study (CCPS) is a multi-center, longitudinal, observational study that will collect clinical and biological data and specimens from children with a cancer predisposition syndromes (CPS) and their relatives. The central hypothesis is that studying individuals at h…

   Stage

   Not phased

   Ages

   Any age

   Site

   Dana Farber Cancer Institute, Boston, Massachusetts

   Locations

   7 in total

   Run by

   Emory University

   See if you can join NCT04511806 on ClinicalTrials.gov